1. Monash Health
  2. Monash Health research
  3. Articles
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/28968
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGan H.K.en
dc.contributor.authorRaina MacIntyre C.en
dc.contributor.authorKarikios D.en
dc.contributor.authorKaranth N.en
dc.contributor.authorSegelov E.en
dc.contributor.authorYip D.en
dc.contributor.authorUnderhill C.en
dc.contributor.authorPrenen H.en
dc.contributor.authorKarapetis C.en
dc.contributor.authorJackson C.en
dc.contributor.authorNott L.en
dc.contributor.authorClay T.en
dc.contributor.authorPavlakis N.en
dc.contributor.authorSabesan S.en
dc.contributor.authorHeywood E.en
dc.contributor.authorSteer C.en
dc.contributor.authorLethborg C.en
dc.date.accessioned2021-05-14T09:46:01Zen
dc.date.available2021-05-14T09:46:01Zen
dc.date.copyright2020en
dc.date.created20201109en
dc.date.issued2020-11-09en
dc.identifier.citationJCO Oncology Practice. 16 (8) (pp 467-482), 2020. Date of Publication: 2020.en
dc.identifier.issn2688-1527en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/28968en
dc.description.abstractCancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.Copyright © 2020 by American Society of Clinical Oncology.en
dc.languageEnglishen
dc.languageenen
dc.publisherAmerican Society of Clinical Oncology (E-mail: jcoservice@asco.org)en
dc.relation.ispartofJCO Oncology Practice-
dc.titlePractical considerations for treating patients with cancer in the COVID-19 pandemic.en
dc.typeArticleen
dc.identifier.affiliationOncology-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1200/OP.20.00229-
dc.publisher.placeUnited Statesen
dc.identifier.pubmedid32401686 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32401686]en
dc.identifier.source2007647559en
dc.identifier.institution(Segelov) Department of Oncology, Monash University and Monash Health, Melbourne, VIC, Australia (Underhill, Steer) Border Medical Oncology, Albury-Wodonga Regional Cancer Centre, University of NSW Rural Clinical School, Albury Campus, Albury, NSW, Australia (Prenen) Department of Oncology, University Hospital Antwerp, Edegem, Belgium (Karapetis) Department of Medical Oncology, Flinders Medical Centre, Flinders University, Adelaide, SA, Australia (Jackson) Department of Medicine, University of Otago, Dunedin, New Zealand (Nott) Department of Medical Oncology, Royal Hobart Hospital, Hobart, TAS, Australia (Clay) Department of Oncology, St John of God Subiaco Hospital, School of Medicine and Health Sciences, Edith Cowan University, Perth, WA, Australia (Pavlakis) Department of Medical Oncology, Royal North Shore Hospital, Sydney, NSW, Australia (Sabesan) Department of Medical Oncology, Townsville Cancer Centre, Townsville Hospital and Health Services, Townsville, QLD, Australia (Heywood) Cancer Services, Monash Health, Melbourne, VIC, Australia (Lethborg) Inclusive Health Research, St Vincent's Health Australia, Melbourne, VIC, Australia (Gan) Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg, VIC, Australia (Gan) La Trobe University School of Cancer Medicine, Heidelberg, VIC, Australia (Gan) Department of Medicine, University of Melbourne, Heidelberg, VIC, Australia (Yip) Department of Medical Oncology, Canberra Hospital, ANU Medical School, Australian National University, Canberra, ACT, Australia (Karanth) Department of Medicine, Royal Darwin Hospital, Darwin, NT, Australia (Karikios) Department of Medical Oncology, Nepean Hospital and Nepean Clinical School, Sydney Medical School, University of Sydney, Sydney, NSW, Australia (Raina MacIntyre) Biosecurity Program, Kirby Institute, University of New South Wales, Sydney, NSW, Australia (Segelov) Monash Health and Monash University, Level 7, MHTP Building, Monash Health, 246 Clayton Rd, Clayton, VIC 3168, Australiaen
dc.description.addressE. Segelov, Department of Oncology, Monash University and Monash Health, Melbourne, VIC, Australia. E-mail: eva.segelov@monash.eduen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailSegelov E.; eva.segelov@monash.eduen
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptOncology-
Appears in Collections:Articles
Show simple item record

Page view(s)

18
checked on Oct 7, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.